Skip to main content
OpenTrials

Clinical trial condition

Lymphangioleiomyomatosis

Explore clinical trials studying Lymphangioleiomyomatosis. Study availability and eligibility vary by location and protocol.

31 public trials 7 recruiting studies
Refine in advanced search Browse all conditions

Lymphangioleiomyomatosis trial results

Completed

Efficacy and Safety of Sirolimus in LAM

NCT00414648

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations
  • University of California Los Angeles Los Angeles, California, United States
  • National Jewish Medical and Research Center Denver, Colorado, United States
  • University of Florida, Gainesville Gainesville, Florida, United States
  • National Heart, Lung, and Blood Institute Bethesda, Maryland, United States
View all 13 locations
View Trial Details
Completed

A Study to Determine the Safety and Effectiveness of RAD001 (Everolimus) in Patients With Lymphangioleiomyomatosis

NCT01059318

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations
  • Center for LAM Research and Clinical Care Boston, Massachusetts, United States
  • University of Cincinnati, Department of Internal Medicine, Pulmonary, Critical Care & Sleep Medicine, Cincinnati, Ohio, United States
  • Novartis Investigative Site Lyon, France
  • Novartis Investigative Site Milan, Italy
View Trial Details
Completed

Safety of Simvastatin in LAM and TSC

NCT02061397

Conditions
Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, +24 more
Locations
  • University of Pennsylvania Philadelphia, Pennsylvania, United States
View Trial Details
Completed

LAM Pilot Study With Imatinib Mesylate

NCT03131999

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations
  • Columbia University New York, United States
  • Medical University of South Carolina Charleston, South Carolina, United States
View Trial Details

Related conditions